Join
Live feed
·
INSIDERFilingvia Quantisnow
Inovio Pharmaceuticals Inc. logo

Chief Medical Officer Sumner Michael John converted options into 2,917 shares, increasing direct ownership by 55% to 8,219 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
INO· Inovio Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INO (Inovio Pharmaceuticals Inc.) and more on Quantisnow.